1. Home
  2. PRPO vs KAVL Comparison

PRPO vs KAVL Comparison

Compare PRPO & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • KAVL
  • Stock Information
  • Founded
  • PRPO N/A
  • KAVL 1998
  • Country
  • PRPO United States
  • KAVL United States
  • Employees
  • PRPO N/A
  • KAVL N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • KAVL Medicinal Chemicals and Botanical Products
  • Sector
  • PRPO Industrials
  • KAVL Health Care
  • Exchange
  • PRPO Nasdaq
  • KAVL Nasdaq
  • Market Cap
  • PRPO 9.9M
  • KAVL 8.9M
  • IPO Year
  • PRPO N/A
  • KAVL N/A
  • Fundamental
  • Price
  • PRPO $6.68
  • KAVL $1.36
  • Analyst Decision
  • PRPO
  • KAVL
  • Analyst Count
  • PRPO 0
  • KAVL 0
  • Target Price
  • PRPO N/A
  • KAVL N/A
  • AVG Volume (30 Days)
  • PRPO 6.6K
  • KAVL 1.2M
  • Earning Date
  • PRPO 03-28-2025
  • KAVL 03-24-2025
  • Dividend Yield
  • PRPO N/A
  • KAVL N/A
  • EPS Growth
  • PRPO N/A
  • KAVL N/A
  • EPS
  • PRPO N/A
  • KAVL N/A
  • Revenue
  • PRPO $17,411,000.00
  • KAVL $10,108,906.00
  • Revenue This Year
  • PRPO $75.18
  • KAVL $652.90
  • Revenue Next Year
  • PRPO N/A
  • KAVL N/A
  • P/E Ratio
  • PRPO N/A
  • KAVL N/A
  • Revenue Growth
  • PRPO 31.31
  • KAVL N/A
  • 52 Week Low
  • PRPO $4.31
  • KAVL $0.58
  • 52 Week High
  • PRPO $7.20
  • KAVL $9.69
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 57.81
  • KAVL 61.11
  • Support Level
  • PRPO $6.52
  • KAVL $1.13
  • Resistance Level
  • PRPO $7.00
  • KAVL $1.45
  • Average True Range (ATR)
  • PRPO 0.25
  • KAVL 0.18
  • MACD
  • PRPO 0.02
  • KAVL 0.01
  • Stochastic Oscillator
  • PRPO 67.68
  • KAVL 77.35

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

Share on Social Networks: